Why the FDA Wants TV Drug Ads to Use Simpler Words and Lose the Distractions
Clear descriptions of potential risks and side effects will be required under rules that go into effect Nov. 20, even as the ...
CCHR Int9h
CCHR Urges FDA Overhaul to End Psychiatric Drug and Device Harms
The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.
FDA approves 1st new drug to treat schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...
What Robert F. Kennedy Jr. has said about vaccines, fluoride and food dye as Trump nominates him to head the Department of Health and Human Services
President-elect Donald Trump has named Robert F. Kennedy Jr. as his choice for the next secretary of the Department of Health ...
Agenus Top Brass Sued Over FDA Response to Cancer Drug Trial
Executives and directors of Agenus Inc. misled the public about the results of clinical trials for the biotech’s cancer ...
Newsweek20d
Food and Drug Administration
Newsweek magazine delivered to your door Newsweek Voices: Diverse audio opinions Enjoy ad-free browsing on Newsweek.com Comment on articles Newsweek app updates on-the-go ...
Reuters29d
US FDA expands use of Avadel's sleep disorder drug to ages 7 and up
Oct 17 - The U.S. Food and Drug Administration has approved Avadel ... approved for the same condition as Lumryz, Xywav has the FDA's expanded nod to treat idiopathic hypersomnia, a rare ...
FDA Grants Orphan Drug Designation to Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy
Research that was carried out by Baylor College of Medicine and Texas Children’s Hospital doctors have led to the U.S. Food ...
Business Wire1mon
Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-001 for the Treatment of Friedreich's Ataxia
today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to Papillon’s PPL-001, an experimental treatment for Friedreich's ataxia.
MM&M3d
FDA rule on TV drug ads: compliance boon or comprehension bust?
Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...